Pulmonary hypertension is a significant complication in many paediatric disease states. This article discusses current understanding of pulmonary hypertension and includes definition, diagnosis, and management. A description of the latest advances in targeted pharmacological therapy in children is also provided as well as impact on morbidity and mortality.
- pulmonary hypertension
Statistics from Altmetric.com
Dr Ivy is a consultant for INO Therapeutics, Actelion, and Glaxo Smith Kline
Funding: Supported in part by NIH M01-RR00069 from the General Clinical Research Center branch of the National Center for Research Resources, NIH
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.